the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

NCT04430361 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Tumor
Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Megestrol
DRUG: 5-HT3 receptor antagonist
DRUG: dexamethasone

Sponsor

Henan Cancer Hospital